United States· US:0078-0729_c0cc485e-81d4-4204-a894-caa615bea90b
Betoptic S
A betaxolol product containing betaxolol hydrochloride, registered in United States by Novartis Pharmaceuticals Corporation. The same ATC class is registered in 11 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Betaxolol is registered in 11 of 19 countries.
Countries holding a registration under ATC S01ED02 (betaxolol), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Betaxolol · ATC S01ED02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BETAXOLOL HYDROCHLORIDE
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Country
- United States (US)
- ATC code
- S01ED02
- ATC class
- Betaxolol
- Defined daily dose
- 0.2 ml, AT
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1100780729101 BOTTLE in 1 CARTON (0078-0729-10) / 10 mL in 1 BOTTLE
- ndc1100780729151 BOTTLE in 1 CARTON (0078-0729-15) / 15 mL in 1 BOTTLE
- ndc110078-0729-10
- ndc110078-0729-15
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
95 interactions on record for betaxolol.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Betaxolol · interactions on record
95 records
- 8 severe
- 85 moderate
- 2 minor
Most severe, free to view
- TheophyllinC01EB28severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
- SiponimodL04AA42severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Betaxolol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBETAMEDMedochemie Ltd., Limassol
- United KingdomBetaxolol 0.25% eye dropsSigma Pharmaceuticals Plc
- PolandBetaxolol MedregMedreg s.r.o.
- FranceBETAXOLOL BIOGARAN 20 mg, comprimé pelliculé sécableBIOGARAN
- FinlandBetopticImmedica Pharma AB
- BelgiumBetoptic 5 mg/mlNovartis Pharma
- SwitzerlandBetoptic S
- NorwayBetopticImmedica Pharma AB
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Betoptic S
- Belgium · Betoptic, Betoptic S
- Bulgaria · Бетак, Бетоптик S
- Cyprus · Betac
- Czechia · Betamed, Betaxolol Medreg
- Germany · Betoptima, Kerlone
- Denmark · Betoptic S
- Estonia · Betoptic S
- Spain · Betoptic
- Finland · Betoptic, Betoptic S
- France · Betaxolol Biogaran, Betaxolol Eg
- United Kingdom (Northern Ireland) · Betoptic
- Greece · Betoptic, Betoptic S
- Croatia · Betoptic
- Hungary · Betoptic, Lokren
- Italy · Betoptic, Kerlon
- Lithuania · Betac, Betaxolol Pmcs
- Luxembourg · Betoptic, Betoptic S
- Latvia · Betac, Betaxolol Pmcs
- Netherlands · Betoptic S
- Norway · Betoptic, Betoptic S
- Poland · Betaxolol Medreg, Betaxolol Pmcs
- Portugal · Bertocil, Betoptic
- Romania · Betaxolol Gemax Pharma, Betoptic S
- Sweden · Betoptic, Betoptic S
- Slovenia · Betoptic, Betoptic S
- Slovakia · Betac, Betaxolol Medreg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c9a39fd3-68e8-42ac-84f8-217cd02814ea GET /v1/drugs/c9a39fd3-68e8-42ac-84f8-217cd02814ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "2.8",
"substance": "BETAXOLOL HYDROCHLORIDE",
"productndc": "0078-0729",
"dosage_form": "SUSPENSION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA019845",
"marketing_category": "NDA"
}See everything about betaxolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.